We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Medlab Middle East 2023 Showcases Latest Laboratory Innovations and Technologies

By LabMedica International staff writers
Posted on 06 Feb 2023
Print article
Image: Medlab Middle East 2023 has seen a 100% increase in exhibitor numbers (Photo courtesy of Informa Markets)
Image: Medlab Middle East 2023 has seen a 100% increase in exhibitor numbers (Photo courtesy of Informa Markets)

The 22nd edition of Medlab Middle East Congress, is taking place live, in-person from 6-9 February 2023, in Dubai with a 100% increase in exhibitor numbers. Co-hosted with Arab Health for the last two years, Medlab Middle East has more than 700 exhibitors displaying the latest laboratory innovations and technologies to an audience of over 20,000 visitors representing more than 180 countries throughout the show's four days.

The 2023 edition of Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress organized by Informa Markets (London, UK), has returned as a standalone event following unprecedented demand from exhibitors and visitors to attend the show. This year’s exhibition theme ‘paving the way for technological advancements and sustainability in laboratory medicine’ underscores the rate at which laboratory technology has advanced in recent years. In addition to a showcase of products ranging from high-performance solutions and advanced technology to affordable alternatives, Medlab Middle East is revealing a range of new and returning features.

Making its debut at the show is Labpreneur, which gathers the most exciting and promising medical laboratory start-ups from across the world as they actively address the unmet challenges and revolutionize the medical lab industry. The competition features the top 10 innovative early and middle-stage start-ups from across the world, pitching their ground-breaking ideas and battling on stage in front of an esteemed panel of judges, which includes investors, industry experts, and entrepreneurs. Sustainability is also in focus and is being highlighted during the Lab Sustainability Awards. The awards encourage action on various sustainable laboratory areas and link to one of the 17 Sustainable Development Goals (SDGs), part of the 2030 Agenda for Sustainable Development with the winners announced during the last session of the “Sustainability in the lab” conference.

Medlab Middle East is also hosting the LabQ, an inter-college quiz competition focusing on the area of pathology and laboratory medicine for senior graduating college and university students majoring in medical laboratory sciences in the UAE. In addition, the scientific poster competition returning in 2023 is dedicated to helping grow the medical laboratory industry by providing a platform to gain recognition and be published. The winner gets the opportunity to speak at Medlab Asia 2023, which takes place in Bangkok, with flights and accommodation included.

The Medlab Middle East Congress also returns this year, providing education and solutions to advance laboratory skills and improve laboratory functions to over 5,000 conference delegates. With 13 conferences, the Congress is the largest CME-accredited multi-track medical laboratory congress globally, featuring 130+ local and international speakers. This year's conference program includes eight core lab conference tracks​, with a further four new additions addressing Point of Care Testing (POCT), Tech Advances and Clinical Impact, New Trends In Laboratory Medicine, Quality Management in the Lab, and Sustainability in the Lab.

“We have seen the demand for clinical laboratory services increase significantly in the last two years. As such, we’ve witnessed a surge in demand from visitors and exhibitors. COVID-19 undoubtedly put increased focus on the laboratory market. Subsequently, we have seen a wealth of new technology and innovation being adopted, which is driving automation and collaboration with the lab and critical external stakeholders,” said Tom Coleman, Exhibition Director for Inform Markets. “More generally, we have seen factors such as the rising prevalence of chronic illnesses and the resulting need for early diagnostic testing contributing to the growth in the size of the lab market. The speed of technological advances in raising productivity and cost savings will also be a key factor in driving the industry’s growth.”

Related Links:
Informa Markets 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more